These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32301750)

  • 1. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays.
    Lippi G; Salvagno GL; Pegoraro M; Militello V; Caloi C; Peretti A; Gaino S; Bassi A; Bovo C; Lo Cascio G
    Clin Chem Lab Med; 2020 Jun; 58(7):1156-1159. PubMed ID: 32301750
    [No Abstract]   [Full Text] [Related]  

  • 2. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.
    Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M
    Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
    Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
    Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
    J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
    Qian C; Zhou M; Cheng F; Lin X; Gong Y; Xie X; Li P; Li Z; Zhang P; Liu Z; Hu F; Wang Y; Li Q; Zhu Y; Duan G; Xing Y; Song H; Xu W; Liu BF; Xia F
    Clin Chem Lab Med; 2020 Aug; 58(9):1601-1607. PubMed ID: 32609640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological characteristics of COVID-19 patients.
    Zhou M; Zhong J; Bi L; Shang P; Xing Y; Wang B; He J; Xu Y; Luo T; Ma M; Li Q
    Infect Dis (Lond); 2020 Oct; 52(10):749-750. PubMed ID: 32603629
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
    Spicuzza L; Montineri A; Manuele R; Crimi C; Pistorio MP; Campisi R; Vancheri C; Crimi N
    J Infect; 2020 Aug; 81(2):e53-e54. PubMed ID: 32335175
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2.
    Nguyen LS; Laghlam D; De Gonfreville E; Pène F; Rozenberg F; Mira JP
    Crit Care; 2020 Sep; 24(1):573. PubMed ID: 32972451
    [No Abstract]   [Full Text] [Related]  

  • 18. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
    Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y
    Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
    Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
    [No Abstract]   [Full Text] [Related]  

  • 20. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.